Tags

Type your tag names separated by a space and hit enter

Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study.
Lancet. 2020 08 29; 396(10251):603-611.Lct

Abstract

BACKGROUND

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with a 382-nucleotide deletion (∆382) in the open reading frame 8 (ORF8) region of the genome have been detected in Singapore and other countries. We investigated the effect of this deletion on the clinical features of infection.

METHODS

We retrospectively identified patients who had been screened for the ∆382 variant and recruited to the PROTECT study-a prospective observational cohort study conducted at seven public hospitals in Singapore. We collected clinical, laboratory, and radiological data from patients' electronic medical records and serial blood and respiratory samples taken during hospitalisation and after discharge. Individuals infected with the ∆382 variant were compared with those infected with wild-type SARS-CoV-2. Exact logistic regression was used to examine the association between the infection groups and the development of hypoxia requiring supplemental oxygen (an indicator of severe COVID-19, the primary endpoint). Follow-up for the study's primary endpoint is completed.

FINDINGS

Between Jan 22 and March 21, 2020, 278 patients with PCR-confirmed SARS-CoV-2 infection were screened for the ∆382 deletion and 131 were enrolled onto the study, of whom 92 (70%) were infected with the wild-type virus, ten (8%) had a mix of wild-type and ∆382-variant viruses, and 29 (22%) had only the ∆382 variant. Development of hypoxia requiring supplemental oxygen was less frequent in the ∆382 variant group (0 [0%] of 29 patients) than in the wild-type only group (26 [28%] of 92; absolute difference 28% [95% CI 14-28]). After adjusting for age and presence of comorbidities, infection with the ∆382 variant only was associated with lower odds of developing hypoxia requiring supplemental oxygen (adjusted odds ratio 0·07 [95% CI 0·00-0·48]) compared with infection with wild-type virus only.

INTERPRETATION

The ∆382 variant of SARS-CoV-2 seems to be associated with a milder infection. The observed clinical effects of deletions in ORF8 could have implications for the development of treatments and vaccines.

FUNDING

National Medical Research Council Singapore.

Authors+Show Affiliations

National Centre for Infectious Diseases, Singapore; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology, and Research, Singapore; Singapore Immunology Network, Agency for Science, Technology, and Research, Singapore; Department of Biological Sciences, National University of Singapore, Singapore.Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology, and Research, Singapore; Singapore Immunology Network, Agency for Science, Technology, and Research, Singapore.National Public Health Laboratory, Singapore.National Public Health and Epidemiology Unit, National Centre for Infectious Diseases, Singapore.Duke-NUS Medical School, National University of Singapore, Singapore.Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology, and Research, Singapore; Singapore Immunology Network, Agency for Science, Technology, and Research, Singapore.Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology, and Research, Singapore; Singapore Immunology Network, Agency for Science, Technology, and Research, Singapore.Singapore Immunology Network, Agency for Science, Technology, and Research, Singapore.Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology, and Research, Singapore; Singapore Immunology Network, Agency for Science, Technology, and Research, Singapore.Duke-NUS Medical School, National University of Singapore, Singapore.National Public Health and Epidemiology Unit, National Centre for Infectious Diseases, Singapore.Duke-NUS Medical School, National University of Singapore, Singapore; Department of Infectious Diseases, Singapore General Hospital, Singapore.Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Medicine, National University Health System, Singapore.Department of Medicine, Infectious Diseases Service, Ng Teng Fong General Hospital, Singapore.Department of Infectious Diseases, Changi General Hospital, Singapore.Alexandra Hospital, Singapore.Department of General Medicine, Khoo Teck Puat Hospital, Singapore.Department of Laboratory Medicine, Tan Tock Seng Hospital, Singapore.Department of Laboratory Medicine, Tan Tock Seng Hospital, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.National Public Health Laboratory, Singapore.National Centre for Infectious Diseases, Singapore; Bioinformatics Institute, Agency for Science, Technology, and Research, Singapore; Department of Biological Sciences, National University of Singapore, Singapore; Global Initiative on Sharing All Influenza Data, Munich, Germany.National Centre for Infectious Diseases, Singapore; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Saw Swee Hock School of Public Health, National University of Singapore, Singapore.Duke-NUS Medical School, National University of Singapore, Singapore.Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology, and Research, Singapore; Singapore Immunology Network, Agency for Science, Technology, and Research, Singapore.Saw Swee Hock School of Public Health, National University of Singapore, Singapore; Ministry of Health, Singapore.Duke-NUS Medical School, National University of Singapore, Singapore. Electronic address: gavin.smith@duke-nus.edu.sg.National Centre for Infectious Diseases, Singapore; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology, and Research, Singapore; Singapore Immunology Network, Agency for Science, Technology, and Research, Singapore. Electronic address: lisa_ng@immunol.a-star.edu.sg.

Pub Type(s)

Journal Article
Observational Study
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

32822564

Citation

Young, Barnaby E., et al. "Effects of a Major Deletion in the SARS-CoV-2 Genome On the Severity of Infection and the Inflammatory Response: an Observational Cohort Study." Lancet (London, England), vol. 396, no. 10251, 2020, pp. 603-611.
Young BE, Fong SW, Chan YH, et al. Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study. Lancet. 2020;396(10251):603-611.
Young, B. E., Fong, S. W., Chan, Y. H., Mak, T. M., Ang, L. W., Anderson, D. E., Lee, C. Y., Amrun, S. N., Lee, B., Goh, Y. S., Su, Y. C. F., Wei, W. E., Kalimuddin, S., Chai, L. Y. A., Pada, S., Tan, S. Y., Sun, L., Parthasarathy, P., Chen, Y. Y. C., ... Ng, L. F. P. (2020). Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study. Lancet (London, England), 396(10251), 603-611. https://doi.org/10.1016/S0140-6736(20)31757-8
Young BE, et al. Effects of a Major Deletion in the SARS-CoV-2 Genome On the Severity of Infection and the Inflammatory Response: an Observational Cohort Study. Lancet. 2020 08 29;396(10251):603-611. PubMed PMID: 32822564.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study. AU - Young,Barnaby E, AU - Fong,Siew-Wai, AU - Chan,Yi-Hao, AU - Mak,Tze-Minn, AU - Ang,Li Wei, AU - Anderson,Danielle E, AU - Lee,Cheryl Yi-Pin, AU - Amrun,Siti Naqiah, AU - Lee,Bernett, AU - Goh,Yun Shan, AU - Su,Yvonne C F, AU - Wei,Wycliffe E, AU - Kalimuddin,Shirin, AU - Chai,Louis Yi Ann, AU - Pada,Surinder, AU - Tan,Seow Yen, AU - Sun,Louisa, AU - Parthasarathy,Purnima, AU - Chen,Yuan Yi Constance, AU - Barkham,Timothy, AU - Lin,Raymond Tzer Pin, AU - Maurer-Stroh,Sebastian, AU - Leo,Yee-Sin, AU - Wang,Lin-Fa, AU - Renia,Laurent, AU - Lee,Vernon J, AU - Smith,Gavin J D, AU - Lye,David Chien, AU - Ng,Lisa F P, Y1 - 2020/08/18/ PY - 2020/06/25/received PY - 2020/07/30/revised PY - 2020/07/30/accepted PY - 2020/8/22/pubmed PY - 2020/9/9/medline PY - 2020/8/22/entrez SP - 603 EP - 611 JF - Lancet (London, England) JO - Lancet VL - 396 IS - 10251 N2 - BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with a 382-nucleotide deletion (∆382) in the open reading frame 8 (ORF8) region of the genome have been detected in Singapore and other countries. We investigated the effect of this deletion on the clinical features of infection. METHODS: We retrospectively identified patients who had been screened for the ∆382 variant and recruited to the PROTECT study-a prospective observational cohort study conducted at seven public hospitals in Singapore. We collected clinical, laboratory, and radiological data from patients' electronic medical records and serial blood and respiratory samples taken during hospitalisation and after discharge. Individuals infected with the ∆382 variant were compared with those infected with wild-type SARS-CoV-2. Exact logistic regression was used to examine the association between the infection groups and the development of hypoxia requiring supplemental oxygen (an indicator of severe COVID-19, the primary endpoint). Follow-up for the study's primary endpoint is completed. FINDINGS: Between Jan 22 and March 21, 2020, 278 patients with PCR-confirmed SARS-CoV-2 infection were screened for the ∆382 deletion and 131 were enrolled onto the study, of whom 92 (70%) were infected with the wild-type virus, ten (8%) had a mix of wild-type and ∆382-variant viruses, and 29 (22%) had only the ∆382 variant. Development of hypoxia requiring supplemental oxygen was less frequent in the ∆382 variant group (0 [0%] of 29 patients) than in the wild-type only group (26 [28%] of 92; absolute difference 28% [95% CI 14-28]). After adjusting for age and presence of comorbidities, infection with the ∆382 variant only was associated with lower odds of developing hypoxia requiring supplemental oxygen (adjusted odds ratio 0·07 [95% CI 0·00-0·48]) compared with infection with wild-type virus only. INTERPRETATION: The ∆382 variant of SARS-CoV-2 seems to be associated with a milder infection. The observed clinical effects of deletions in ORF8 could have implications for the development of treatments and vaccines. FUNDING: National Medical Research Council Singapore. SN - 1474-547X UR - https://www.unboundmedicine.com/medline/citation/32822564/Effects_of_a_major_deletion_in_the_SARS_CoV_2_genome_on_the_severity_of_infection_and_the_inflammatory_response:_an_observational_cohort_study_ DB - PRIME DP - Unbound Medicine ER -